Literature DB >> 21548013

Reduced bone mineral density in adult patients with Langerhans cell histiocytosis.

Polyzois Makras1, Evangelos Terpos, George Kanakis, Athanasios Papatheodorou, Athanasios D Anastasilakis, Panagiotis Kokkoris, Gregory A Kaltsas.   

Abstract

This retrospective study evaluated bone mineral density (BMD) and bone turnover in adults with LCH. Twenty-five adult patients and 25 matched controls were evaluated with BMD measurement and indices of bone metabolism. A BMD value below the expected range for age (Z-score ≤ - 2.0) was found in 20% of patients; in particular, all postmenopausal women and men over 50-years had either osteoporosis or osteopenia. Patients with active disease had significantly lower Z-scores compared to patients with inactive disease and controls. Reduced bone turnover was found in all 14 patients treated with chemotherapy. No fractures due to osteoporosis were identified during 305.15 patient-years of follow-up.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21548013     DOI: 10.1002/pbc.23166

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?

Authors:  Polyzois Makras; Stergios A Polyzos; Athanasios D Anastasilakis; Evangelos Terpos; Athanasios Papatheodorou; Gregory A Kaltsas
Journal:  Mol Ther       Date:  2012-01       Impact factor: 11.454

Review 2.  Adult Langerhans Cell Histiocytosis and the Skeleton.

Authors:  Danae Georgakopoulou; Athanasios D Anastasilakis; Polyzois Makras
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

3.  A long-term trajectory of bone mineral density in childhood cancer survivors after discontinuation of treatment: retrospective cohort study.

Authors:  Eryk Latoch; Jerzy Konstantynowicz; Maryna Krawczuk-Rybak; Anna Panasiuk; Katarzyna Muszyńska-Rosłan
Journal:  Arch Osteoporos       Date:  2021-02-26       Impact factor: 2.617

Review 4.  Bone fragility in patients affected by congenital diseases non skeletal in origin.

Authors:  L Masi; S Ferrari; M K Javaid; S Papapoulos; D D Pierroz; M L Brandi
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

Review 5.  Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net.

Authors:  Michael Girschikofsky; Maurizio Arico; Diego Castillo; Anthony Chu; Claus Doberauer; Joachim Fichter; Julien Haroche; Gregory A Kaltsas; Polyzois Makras; Angelo V Marzano; Mathilde de Menthon; Oliver Micke; Emanuela Passoni; Heinrich M Seegenschmiedt; Abdellatif Tazi; Kenneth L McClain
Journal:  Orphanet J Rare Dis       Date:  2013-05-14       Impact factor: 4.123

Review 6.  Bone metabolism in Langerhans cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Marina Tsoli; Gregory Kaltsas; Polyzois Makras
Journal:  Endocr Connect       Date:  2018-07-02       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.